
Tho V. Duong
Examiner (ID: 6107, Phone: (571)272-4793 , Office: P/3744 )
| Most Active Art Unit | 3744 |
| Art Unit(s) | 3743, 3744, 3753, 3763 |
| Total Applications | 2124 |
| Issued Applications | 1350 |
| Pending Applications | 144 |
| Abandoned Applications | 669 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16175350
[patent_doc_number] => 20200222318
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => CLOTTING FACTOR PREPARATIONS FOR DELIVERY INTO TISSUE OF THE INTESTINAL TRACT USING A SWALLOWABLE DRUG DELIVERY DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/790540
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790540
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790540 | Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device | Feb 12, 2020 | Issued |
Array
(
[id] => 16086983
[patent_doc_number] => 20200197478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => USE OF ANTIMICOBIAL PEPTIDES FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/790666
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790666
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790666 | Use of antimicrobial peptides for treatment of cancer | Feb 12, 2020 | Issued |
Array
(
[id] => 16086985
[patent_doc_number] => 20200197479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-25
[patent_title] => USE OF ANTIMICOBIAL PEPTIDES FOR TREATMENT OF INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/790669
[patent_app_country] => US
[patent_app_date] => 2020-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3534
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16790669
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/790669 | Use of antimicobial peptides for treatment of infection | Feb 12, 2020 | Issued |
Array
(
[id] => 17627259
[patent_doc_number] => 20220162274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => PRODUCTION AND USES OF ARTIFICAL HISTONE H1 FOR ANALYZING, DIAGNOSING, TREATING, AND/OR PREVENTING SENESCENCE
[patent_app_type] => utility
[patent_app_number] => 17/430241
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8995
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17430241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/430241 | PRODUCTION AND USES OF ARTIFICAL HISTONE H1 FOR ANALYZING, DIAGNOSING, TREATING, AND/OR PREVENTING SENESCENCE | Feb 10, 2020 | Abandoned |
Array
(
[id] => 16236831
[patent_doc_number] => 20200254065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-13
[patent_title] => LONG-ACTING GLP-2 ANALOGS
[patent_app_type] => utility
[patent_app_number] => 16/787810
[patent_app_country] => US
[patent_app_date] => 2020-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19151
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16787810
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/787810 | LONG-ACTING GLP-2 ANALOGS | Feb 10, 2020 | Abandoned |
Array
(
[id] => 15993445
[patent_doc_number] => 20200172593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => INSULIN DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 16/784643
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 296
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784643
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784643 | INSULIN DERIVATIVES | Feb 6, 2020 | Abandoned |
Array
(
[id] => 17505147
[patent_doc_number] => 20220098249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => ANTIMICROBIAL NCR2 PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/310582
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33411
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -117
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310582
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310582 | ANTIMICROBIAL NCR2 PEPTIDES | Feb 6, 2020 | Pending |
Array
(
[id] => 17563416
[patent_doc_number] => 20220127565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => A Self-Assembling Short Amphiphilic Peptide And Related Methods And Uses
[patent_app_type] => utility
[patent_app_number] => 17/429132
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429132
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/429132 | A Self-Assembling Short Amphiphilic Peptide And Related Methods And Uses | Feb 6, 2020 | Abandoned |
Array
(
[id] => 16533316
[patent_doc_number] => 10875900
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-29
[patent_title] => Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells
[patent_app_type] => utility
[patent_app_number] => 16/782544
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 6787
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782544
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/782544 | Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells | Feb 4, 2020 | Issued |
Array
(
[id] => 17503495
[patent_doc_number] => 20220096597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF)
[patent_app_type] => utility
[patent_app_number] => 17/428508
[patent_app_country] => US
[patent_app_date] => 2020-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428508
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428508 | CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF) | Feb 4, 2020 | Abandoned |
Array
(
[id] => 17561736
[patent_doc_number] => 20220125885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-28
[patent_title] => GLUCAGON ANALOG AGONISTS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/427782
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13085
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427782 | GLUCAGON ANALOG AGONISTS AND METHODS OF USING THE SAME | Jan 28, 2020 | Abandoned |
Array
(
[id] => 15931051
[patent_doc_number] => 20200157159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => PEPTIDE COMPOUNDS AND COMPOSITIONS THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/775877
[patent_app_country] => US
[patent_app_date] => 2020-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27101
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16775877
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/775877 | PEPTIDE COMPOUNDS AND COMPOSITIONS THEREOF | Jan 28, 2020 | Abandoned |
Array
(
[id] => 16206533
[patent_doc_number] => 20200239523
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/774686
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41460
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774686
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774686 | NOVEL a4B7 THIOETHER PEPTIDE DIMER ANTAGONISTS | Jan 27, 2020 | Abandoned |
Array
(
[id] => 17407155
[patent_doc_number] => 11248024
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Noxa-derived, cell death-inducing peptide eMTD
[patent_app_type] => utility
[patent_app_number] => 16/774423
[patent_app_country] => US
[patent_app_date] => 2020-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 6556
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16774423
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/774423 | Noxa-derived, cell death-inducing peptide eMTD | Jan 27, 2020 | Issued |
Array
(
[id] => 17272994
[patent_doc_number] => 20210379192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => SKELETAL MUSCLE TARGETING MOIETIES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/300507
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33190
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300507
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300507 | SKELETAL MUSCLE TARGETING MOIETIES AND USES THEREOF | Jan 26, 2020 | Abandoned |
Array
(
[id] => 16341720
[patent_doc_number] => 20200306370
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-01
[patent_title] => AMINO ACID AND PEPTIDE CONJUGATES AND CONJUGATION PROCESS
[patent_app_type] => utility
[patent_app_number] => 16/773241
[patent_app_country] => US
[patent_app_date] => 2020-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16773241
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/773241 | AMINO ACID AND PEPTIDE CONJUGATES AND CONJUGATION PROCESS | Jan 26, 2020 | Abandoned |
Array
(
[id] => 16190792
[patent_doc_number] => 20200231641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-23
[patent_title] => METHODS AND COMPOSITIONS FOR VISUALIZING SUMO
[patent_app_type] => utility
[patent_app_number] => 16/744889
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744889
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/744889 | METHODS AND COMPOSITIONS FOR VISUALIZING SUMO | Jan 15, 2020 | Abandoned |
| 16/742195 | PEPTIDE, COMPOSITION AND METHOD FOR ANTI-HAIR GRAYING | Jan 13, 2020 | Abandoned |
Array
(
[id] => 16504860
[patent_doc_number] => 20200384116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => SELF-ASSEMBLING VERTEPORFIN AMPHIPHILES (SAVA) FOR LOCAL CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/739956
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16739956
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/739956 | SELF-ASSEMBLING VERTEPORFIN AMPHIPHILES (SAVA) FOR LOCAL CANCER THERAPY | Jan 9, 2020 | Abandoned |
Array
(
[id] => 18902705
[patent_doc_number] => 20240018190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => CONDUCTIVE SYNTHETIC PEPTIDES FOR MOLECULAR ELECTRONICS
[patent_app_type] => utility
[patent_app_number] => 17/373763
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17373763
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/373763 | CONDUCTIVE SYNTHETIC PEPTIDES FOR MOLECULAR ELECTRONICS | Jan 9, 2020 | Pending |